AstraZeneca's facility in Speke, UK (Image: AstraZeneca)
March 6, 2024 11:12 AM EST
Manufacturing

As­traZeneca al­lo­cates £650M to boost its UK man­u­fac­tur­ing, cam­pus foot­print 

Anna Brown

News Reporter

As­traZeneca is look­ing to spend £450 mil­lion ($827.1 mil­lion) to ex­pand its UK vac­cine man­u­fac­tur­ing site, on top of a £200 bud­get ($254.4 mil­lion) on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times